Similar articles

• SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.

  Clerc J, Halpern S, Fourré C, Omri F, Briançon C, Jeusset J, Fragu P. Clerc J, et al. J Nucl Med. 1993 Sep;34(9):1565-70. J Nucl Med. 1993. PMID: 8355077
• No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.

  Mairs RJ, Cunningham SH, Russell J, Armour A, Owens J, McKellar K, Gaze MN. Mairs RJ, et al. J Nucl Med. 1995 Jun;36(6):1088-95. J Nucl Med. 1995. PMID: 7769433
• Therapeutic use of I-131-MIBG in nude mice hosting human neuroblastoma xenografts.

  Senekowitsch R, Laubenbacher C, Möllenstädt S, Kriegel H, Pabst HW. Senekowitsch R, et al. Strahlenther Onkol. 1989 Jul;165(7):566-8. Strahlenther Onkol. 1989. PMID: 2749502 No abstract available.
• Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.

  Smets LA, Rutgers M. Smets LA, et al. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):191-4. J Nucl Biol Med (1991). 1991. PMID: 1823816 Review. No abstract available.
• Radiolabelled mIBG in the treatment of neuroblastoma.

  Gaze MN, Wheldon TE. Gaze MN, et al. Eur J Cancer. 1996 Jan;32A(1):93-6. doi: 10.1016/0959-8049(95)00511-0. Eur J Cancer. 1996. PMID: 8695251 Review. No abstract available.